C83.44 Immunoblastic (diffuse) non-Hodgkin's lymphoma, lymph nodes of axilla and upper limb

Name of the Condition

• Immunoblastic (diffuse) non-Hodgkin's lymphoma, lymph nodes of axilla and upper limb
• Also known as ICD-10 code C83.44

Summary

Immunoblastic (diffuse) non-Hodgkin's lymphoma is a subtype of non-Hodgkin lymphoma characterized by the malignant proliferation of immunoblasts, a type of immature B-cell. It typically involves diffuse growth patterns in lymph nodes or other lymphoid tissues, with a tendency for rapid progression. This condition is part of the broader category of non-follicular lymphomas and may present with variable clinical behavior depending on the specific subtype.

Causes

The exact cause of immunoblastic (diffuse) non-Hodgkin's lymphoma remains unknown. It is thought to involve genetic mutations or abnormalities in B-cell development, though specific triggers are not well-defined. Research suggests potential links to immune system dysregulation or prior infections, but no definitive etiology has been established.

Risk Factors

• Age: More common in older adults.
• Family history of lymphoma.
• Prior exposure to radiation or certain chemicals.
• Chronic infections, such as hepatitis C or HIV.
• Immunosuppressive conditions or treatments.

Symptoms

• Swollen, painless lymph nodes.
• Unexplained weight loss.
• Fever.
• Night sweats.
• Fatigue.
• Loss of appetite.

Diagnosis

Diagnosis involves a combination of physical examination, imaging studies (e.g., CT or MRI), and biopsy of affected lymph nodes. Histopathological analysis confirms the presence of immunoblasts and diffuse growth patterns. Additional tests, such as flow cytometry or molecular studies, may be used to characterize the subtype and assess for specific genetic markers.

Treatment Options

Treatment depends on the stage, patient health, and subtype. Options may include chemotherapy, immunotherapy, radiation therapy, or targeted therapies. Stem cell transplantation may be considered for advanced or refractory cases. Treatment plans are individualized based on clinical assessment.

Prognosis and Follow-Up

Prognosis varies based on factors like age, overall health, and disease stage. Regular follow-up with imaging and clinical evaluations is essential to monitor for recurrence or progression. Long-term survival rates depend on response to treatment and underlying risk factors.

Complications

Potential complications include infection due to immunosuppression, organ dysfunction from tumor burden, treatment-related toxicities, and transformation to more aggressive lymphoma subtypes.

Lifestyle & Prevention

Maintaining a healthy lifestyle, avoiding known carcinogens (e.g., tobacco, excessive radiation), and managing chronic infections may help reduce risk. Regular medical check-ups are recommended for early detection in high-risk individuals.

When to Seek Professional Help

Seek medical attention for persistent swollen lymph nodes, unexplained weight loss, fever, or fatigue. Prompt evaluation is crucial for timely diagnosis and treatment.

Tips for Medical Coders

Use C83.44 for immunoblastic (diffuse) non-Hodgkin's lymphoma specifically involving lymph nodes of the axilla and upper limb. Ensure documentation supports the anatomical site and histological subtype. Verify that the code aligns with the patient's clinical presentation and diagnostic findings.